Seymour H. Fein

Seymour H. Fein

Chief Tech/Sci/R&D Officer bei ONCOTELIC THERAPEUTICS, INC.

75 Jahre
Health Technology
Consumer Services
Finance

Profil

Seymour H.
Fein
is the founder of Serenity Pharmaceuticals Corp.
(founded in 2007) where he holds the title of Chief Medical Officer & Principal.
He is currently the Chief Medical & Regulatory Officer at Oncotelic Therapeutics, Inc. (since 2022) and the Chief Medical Officer at Ventria Bioscience, Inc. (since 2015).
In his former positions, he served as a Medical Director at Bayer Pharmaceuticals Corp., Bayer HealthCare Pharmaceuticals, Inc., Ohmeda PPD, Inc., Rorer Group, Inc., and Ohmeda, Inc. He was also a Director-Clinical Research & Development at Ohmeda PPD, Inc. Additionally, he held the position of Independent Director at Prospect Park Capital Corp.
from 2016 to 2020.
Dr. Fein was the Chief Medical Officer at Oncotelic Therapeutics, Inc. and Delcath Systems, Inc. from 2006 to 2008.
He also worked as a Senior Research Physician at Hoffmann-La Roche, Inc. and as a Principal at the US Food & Drug Administration.
Dr. Fein obtained his undergraduate degree from the University of Pennsylvania and his doctorate from New York Medical College.

Aktive Positionen von Seymour H. Fein

UnternehmenPositionBeginn
ONCOTELIC THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 28.02.2023
Chief Tech/Sci/R&D Officer 11.05.2015
Founder 01.01.2007
Alle aktiven Positionen von Seymour H. Fein

Ehemalige bekannte Positionen von Seymour H. Fein

UnternehmenPositionEnde
PROSPECT PARK CAPITAL CORP. Director/Board Member 23.01.2020
DELCATH SYSTEMS, INC. Chief Tech/Sci/R&D Officer 17.07.2008
ONCOTELIC THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
ADHERA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
Bayer Pharmaceuticals Corp. Chief Tech/Sci/R&D Officer -
Sehen Sie sich die Erfahrung von Seymour H. Fein im Detail an

Ausbildung von Seymour H. Fein

University of Pennsylvania Undergraduate Degree
New York Medical College Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Seymour H. Fein im Detail an

Beziehungen

40

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
ONCOTELIC THERAPEUTICS, INC.

Health Technology

DELCATH SYSTEMS, INC.

Health Technology

PROSPECT PARK CAPITAL CORP.

Finance

ADHERA THERAPEUTICS, INC.

Health Technology

Private Unternehmen9
Bayer Pharmaceuticals Corp.

Health Technology

Government

Health Technology

Health Technology

Ohmeda PPD, Inc.

Health Technology

Health Technology

Ohmeda, Inc.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Seymour H. Fein